Search
Browse
Statistics
Feeds

Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
9MB
[thumbnail of Supplementary Data] Other (Supplementary Data)
17MB

Item Type:Article
Title:Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature
Creators: Domenichini, Mattia, Corsini, Michela, Ravelli, Cosetta, Ricci, Anastasia, Moreschi, Elisa, Grillo, Elisabetta, Maggi, Camilla, Baldanzi, Gianluca, Chiodini, Sonia, Sanchez-Amador, Diana Eveline, Kraxner, Julia ORCID logoORCID: https://orcid.org/0000-0002-3515-7468, Monaghan, Michael G., Gerhardt, Holger ORCID logoORCID: https://orcid.org/0000-0002-3030-0384, Menotta, Michele and Mitola, Stefania
Abstract:Solid tumors are highly dynamic environments, in which endothelial cells (ECs) interface with blood, cancer cells, and the extracellular matrix (ECM), thereby regulating tumor behavior and metastatic dissemination. We recently showed that aberrant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) activation promotes tumor progression through ECM remodeling. Here we investigated whether VEGFR2-driven ECM remodeling affects EC behavior and vessel stability. Using decellularized ECM from Sk-Mel-31 melanoma cells expressing either VEGFR2(WT) or the aberrant VEGFR2(R1032Q) mutant, we found that VEGFR2(R1032Q) reshapes ECM composition, including core matrisome components, ECM-modifying enzymes, and vascular-associated proteins. ECs seeded on VEGFR2(R1032Q)-derived ECM displayed altered adhesion dynamics, characterized by focal adhesion remodeling, increased haptotaxis, and impaired morphogenic capacity. This remodeled ECM also induced cytoskeletal reorganization and, disruption of VE-cadherin junctions via RhoA activation. Consistently, VEGFR2(R1032Q)-derived tumors exhibited more immature vessels with discontinuous junctions and the expression of mesenchymal markers. Under laminar flow, ECs exposed to VEGFR2(R1032Q)-ECM showed a delayed calcium dynamic, altered YAP localization, defective polarization, actin alignment and impaired shear-stress adaptation. Overall, these findings identify VEGFR2-driven ECM remodeling as a non-cell-autonomous mechanism that destabilizes tumor vasculature by impairing endothelial adhesion, mechanosensing, and junctional integrity, highlighting tumor/ECM/endothelium crosstalk as a potential therapeutic vulnerability.
Keywords:Tumoral Vasculature, Extracellular Matrix, Mechanosensing, Endothelial-to-Mesenchymal Transition, Focal Adhesion, Cell-Cell Junction, Animals
Source:Cancer Letters
ISSN:0304-3835
Publisher:Elsevier
Volume:661
Page Range:218848
Date:28 November 2026
Official Publication:https://doi.org/10.1016/j.canlet.2026.218848
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library